Mike Ritchie

Mike Ritchie has over 20 years of experience in oncology research and drug development. He earned his PhD in Biochemistry from Temple University School of Medicine and completed a postdoctoral fellowship in Neuroscience at Harvard Medical School. Earlier in his career, he led therapeutic programs at Pfizer, and for the past decade at Champions Oncology he has advanced the use of patient-derived models and multi-omic platforms. A recognised thought leader, he shares insights on translational models, radiopharmaceuticals and AI-driven analytics to accelerate oncology pipelines and reduce risk.